nDatalyze Corp. generates technology-based, health-related solutions. The YMI division is developing a machine-learning based, online consumer mental health application and the database sales division is focusing on providing a specialized health-related Reference Database to application developers and researchers. YMI is based on the Corporation's proprietary Reference Database consisting of >1200 biometric records complete with electroencephalogram ("EEG") "same-time-of-day" data. With installations worldwide, it's Medxtractor division manufactures small-scale bio-extractors that are used to extract compounds from a variety of botanical biomasses. While the Medxtractor division is currently generating cash flow, YMI is in development and accordingly the Corporation cannot accurately predict if or when this application will become a cash flow generator. Investors are encouraged to contact the Corporation by email at email@example.com or by telephone at (403) 689-3901.
nDatalyze Corp. (NDAT)
le 20 octobre/October 2021
MedXtracator Corp. has announced a name and symbol change to nDatalyze Corp. (NDAT)
Shares will begin trading under the new name, symbol and with a new CUSIP number on October 22, 2021.
Disclosure documents are available at www.thecse.com